Literature DB >> 10732815

Homozygosity mapping of giant axonal neuropathy gene to chromosome 16q24.1.

C Ben Hamida1, L Cavalier, S Belal, H Sanhaji, N Nadal, C Barhoumi, N M'Rissa, N Marzouki, J L Mandel, M Ben Hamida, M Koenig, F Hentati.   

Abstract

Giant axonal neuropathy (GAN) is a rare autosomal recessive disorder described as a symmetrical distal neuropathy, with peripheral axons dilated by accumulation of 10 nm neurofilaments (NF) and a severe course of the disease. The observation of kinky or curly hairs is not a constant finding. The GAN1 locus was localized by homozygosity mapping to chromosome 16 q24.1 in a 3 (4) cM interval flanked by the markers D16S3073 and D16S505 (D16S511) in three non-related Tunisian families, showing a genetic homogeneity in these families. Two point lod-score calculation between the linked haplotype and the disease locus was 14.2 at theta(max) = 0. The patients share a slow course of the disease. The differences in the course of the disease between Tunisian and non-Tunisian patients suggest a possible genetic heterogeneity, which is why the present linkage has been referred to as GAN1. The biochemical defect in GAN1 should help to understand the mechanisms involved in NF accumulations as in other neurological diseases (ALS, SMA).

Entities:  

Mesh:

Year:  1997        PMID: 10732815     DOI: 10.1007/s100480050019

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  8 in total

1.  Giant axonal neuropathy: clinical and genetic study in six cases.

Authors:  E Demir; P Bomont; S Erdem; L Cavalier; M Demirci; G Kose; S Muftuoglu; A N Cakar; E Tan; S Aysun; M Topcu; P Guicheney; M Koenig; H Topaloglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

2.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

3.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

4.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

5.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

Review 6.  Human iPSC-Derived Astrocytes: A Powerful Tool to Study Primary Astrocyte Dysfunction in the Pathogenesis of Rare Leukodystrophies.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Pompeo Macioce; Sergio Visentin; Elena Ambrosini
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

7.  Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin.

Authors:  Jianqing Ding; Jia-Jia Liu; Anthony S Kowal; Timothy Nardine; Priyanka Bhattacharya; Arthur Lee; Yanmin Yang
Journal:  J Cell Biol       Date:  2002-07-29       Impact factor: 10.539

Review 8.  E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy.

Authors:  Léa Lescouzères; Pascale Bomont
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.